US 11702478
Agonistic CD40 antibodies
granted A61KA61K2039/505A61P
Quick answer
US patent 11702478 (Agonistic CD40 antibodies) held by MAB Discovery GmbH expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MAB Discovery GmbH
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00